People: Transition Therapeutics Inc (TTH.TO)
21 Jun 2016
Dr. Bruce Connop is Vice President - Non-Clinical & Pharmaceutical Development of Transition Therapeutics Inc. Dr. Connop has been with Transition since 2006 and served as Sr. Director, Nonclinical Drug Development until he was appointed VP, Non-Clinical & Pharmaceutical Development in 2012. With his expertise in pharmacology, toxicology and manufacturing he is responsible for a broad range of activities and has made significant contributions to the advancement of pipeline products. Dr. Connop holds a Ph.D. from Queen’s University and has had experience at other biotech and pharmaceutical companies.
|Total Annual Compensation, CAD||194,782|
|Restricted Stock Awards, CAD||--|
|Long-Term Incentive Plans, CAD||--|
|All Other, CAD||92,400|
|Fiscal Year Total, CAD||287,182|